OTC · AMBS
Healthcare · Biotechnology
$0.00
Up+$0.00 (+0.00%)
Updated Sep 13, 2026, 2:00 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 6 trading sessions · Daily adjusted prices
AMBS closed at $0.00 after 6 trading sessions.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 3, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 1.5K |
| Sep 2, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 480 |
| Aug 31, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 100K |
| Aug 24, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 1.27M |
| Aug 19, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 754 |
| Aug 18, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 334 |
The latest Smart Investors Daily articles mentioning AMBS.
AMBS research
Company profile and research snapshot.
AMARANTUS BIOSCIENCE HLDG
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
defenseworld.net · Dec 5, 2025
Amarantus Bioscience (OTCMKTS:AMBS - Get Free Report) and PACS Group (NYSE: PACS - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, analyst recommendations, earnings and institutional ownership. Analyst Ratings This is a summary of recent
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AMBS.
No results
No recent SID articles mention AMBS.
